In their letter, the Members underscored that ending fossil fuel subsidies is an essential step in achieving #environmentaljustice in the United States.
Studies indicate that the pollution generated by the fossil fuel industry disproportionately affects the health and well-being of communities of color.
According to @IMFNews, the U.S. government ranks second in the world in its support of the oil and gas industry, giving the fossil fuel industry over $20.5 BILLION in support each year through tax breaks, inadequate royalty rates, and direct funding!
📢 It’s time to end fossil fuel subsidies and invest in clean energy infrastructure
• • •
Missing some Tweet in this thread? You can try to
force a refresh
NEW: Chairs @RepMaloney and @RepStephenLynch issued the following statement after Special Inspector General for Afghanistan Reconstruction (SIGAR) John F. Sopko provided a remote briefing to Members of the Committee on Oversight and Reform:oversight.house.gov/news/press-rel…
SIGAR Sopko provided the following information during the briefing ⬇️
Mr. Sopko told the Committee that the collapse of the Afghan Government was the result of a “series of mistakes that were made” across multiple administrations.
NEW: Chair @CongressmanRaja sent a letter to @US_FDA Acting Commissioner @DrWoodcockFDA applauding FDA’s decision to bar the sale of certain flavored e-cigarette products and expressing concern over its decision to distinguish menthol from the other kid-friendly flavors.
FDA’s decision to distinguish menthol from other kid-friendly flavors is a stark contrast to Dr. Woodcock’s congressional testimony.
On June 23, 2021, @DrWoodcockFDA testified before the Subcommittee that menthol in e-cigarettes is:
🔘 “like having a higher concentration of nicotine in your delivery system,”
🔘 “heightens the addictiveness of nicotine in e-cigarettes,”
🔘 “makes it harder to stop vaping.”
NEW: @OversightDems released notes taken by then-Acting Deputy AG Donoghue of a 12/27/20 call with Pres. #Trump & former Acting AG Rosen, revealing attempts by Trump to pressure the 2 most senior officials at the DOJ to help overturn the #2020election or risk losing their jobs.
These handwritten notes of the December 27, 2020, meeting provide additional evidence that former President Trump pressured top DOJ officials to take official action to overturn the results of the 2020 election👇
On July 10th, Texas legislators heard hours and hours of testimony from Texas citizens, the vast majority of whom opposed a bill that would restrict their voting rights.
Listen below to what they had to say about this bill⬇️
▶️ Sonia González-Gladstein argues that the bill does, in fact, impair the right of free suffrage for the people of Texas and that it would have the biggest impact on essential workers and people of color, in a state that is already the hardest to vote in, in the country.
▶️ Alexander Montalvo explains how preventing election officials from ensuring Texans get mail-in ballots and banning drive-thru voting and 24-hour voting are voter suppression.
This Thursday at 10 a.m. ET, the Civil Rights and Civil Liberties Subcommittee will hear from 3 of the brave @TexasHDC who came to DC to defend the #votingrights of their constituents and of every American.
Watch how our witnesses have already spoken up for TX voters ⬇️
▶️ In a news conference about the Texas Dems' escape to DC, Rep. Senfronia Thompson recalls what it was like for her grandmother to vote, at a time when primary elections were "White Only."
▶️ Rep. Nicole Collier talks about the motivation behind the Texas Republicans' attempts to restrict voting rights and silence the voice of Black, Brown, and women of color voters.
For more than two years, @OversightDems have been investigating the pharmaceutical industry’s pricing and business practices
Today, we are releasing our seventh staff report.
The findings are shocking. This is what we know ⬇️
The staff report analyzed financial data from 14 of the largest drug companies, evaluating how much they spent to enrich investors and executives, the amount spent on R&D, and the potential impact of Medicare price negotiations. bit.ly/3jSu7do
From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.